Organization
Stavanger University Hospital
3 abstracts
Abstract
Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1).Org: Institute of Clinical Medicine, University of Oslo, Institute of Clinical Sciences, Department of Surgery, The Sahlgrenska Academy, University of Gothenburg, Department of Biomedical and Clinical Sciences, Linköping University, Clatterbridge Cancer Centre NHS FT, School of Health Sciences, University of Skövde,
Abstract
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).Org: Norwegian University of Science and Technology (NTNU), Department of Thoracic Medicine, Haukeland University Hospital, Department of Oncology, Oslo University Hospital, Oslo, Oslo, Norway, Stavanger University Hospital, Department of Oncology, Odense University Hospital,
Abstract
IMPRESS-Norway: Improving public cancer care by implementing precision cancer medicine in Norway.Org: University of Oslo, Division of Cancer Medicine, Oslo University Hospital, Division of Cancer Medicine, Oslo, Norway, Institute of Clinical Medicine, Oslo Universitetssykehus, Oslo, Norway,